Patents by Inventor D. Andrew Wellman

D. Andrew Wellman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION PHARMACOLOGICAL INTERVENTIONS FOR MULTIPLE MECHANISMS OF OBSTRUCTIVE SLEEP APNEA
    Publication number: 20220362221
    Abstract: In general, the invention relates to pharmaceutical compositions comprising a norepinephrine reuptake inhibitor (NRI), muscarinic receptor antagonist, and carbonic anhydrase inhibitor and methods of treating Sleep Apnea comprising the administration of these pharmaceutical compositions.
    Type: Application
    Filed: November 3, 2020
    Publication date: November 17, 2022
    Inventors: Lawrence G. MILLER, Ronald FARKAS, D. Andrew WELLMAN, Luigi TARANTO-MONTEMURRO, Scott Aaron SANDS
  • METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA
    Publication number: 20220096401
    Abstract: Methods and compositions for the treatment of conditions associated with pharyngeal airway muscle collapse while the subject is in a non-fully conscious state, e.g., sleep apnea and snoring, comprising administration of (i) a norepinephrine reuptake inhibitor (NRI) and (ii) a non myorelaxing hypnotic and/or 5-HT2A inverse agonist or antagonist.
    Type: Application
    Filed: February 7, 2020
    Publication date: March 31, 2022
    Inventors: Luigi Taranto Montemurro, D. Andrew Wellman
  • METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA
    Publication number: 20210401777
    Abstract: Methods and compositions for the treatment of conditions associated with pharyngeal airway muscle collapse while the subject is in a non-fully conscious state, e.g., sleep apnea and snoring, comprising administration of a norepinephrine reuptake inhibitor (NRI) and a muscarinic receptor antagonist.
    Type: Application
    Filed: September 10, 2021
    Publication date: December 30, 2021
    Inventors: D. Andrew Wellman, Luigi Taranto-Montemurro
  • Methods and compositions for treating sleep apnea
    Patent number: 11123313
    Abstract: Methods and compositions for the treatment of conditions associated with pharyngeal airway muscle collapse while the subject is in a non-fully conscious state, e.g., sleep apnea and snoring, comprising administration of a norepinephrine reuptake inhibitor (NRI) and a muscarinic receptor antagonist.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: September 21, 2021
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: D. Andrew Wellman, Luigi Taranto-Montemurro
  • METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA
    Publication number: 20200054583
    Abstract: Methods and compositions for the treatment of conditions associated with pharyngeal airway muscle collapse while the subject is in a non-fully conscious state, e.g., sleep apnea and snoring, comprising administration of a norepinephrine reuptake inhibitor (NRI) and a muscarinic receptor antagonist.
    Type: Application
    Filed: April 26, 2018
    Publication date: February 20, 2020
    Inventors: D. Andrew Wellman, Luigi Taranto-Montemurro